NCT01653405View on ClinicalTrials.gov

Improving Anticoagulation Control in VISN 1

NACompletedINTERVENTIONAL
Enrollment

1,260,576

Participants

Timeline

Start Date

October 1, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
AnticoagulantsAtrial FibrillationVenous Thromboembolism
Interventions
OTHER

Multifaceted behavioral intervention

The intervention included access to a system to measure processes of care relevant to warfarin management, along with targeted audit and feedback.

Trial Locations (1)

01730

Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA, Bedford

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT01653405 - Improving Anticoagulation Control in VISN 1 | Biotech Hunter | Biotech Hunter